Global Bioenergies (ALGBE.PA) Stock Price
Global Bioenergies Price
Over the last 13 years Global Bioenergies grew revenue by 7.0% annually, reaching 360,700.00 EUR. For Global Bioenergies, the net margin of -1,624.9% is up versus -17,446.3% a few years ago. Of 10 analysts, 9 rate the stock a buy — an overall Buy consensus.
Global Bioenergies stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Global Bioenergies over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Global Bioenergies stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Global Bioenergies's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Global Bioenergies Price |
|---|
Global Bioenergies Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Bioenergies Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM EUR |
|---|
| GROSS MARGIN% |
| GROSS INCOMEM EUR |
| EBITM EUR |
| EBIT MARGIN% |
| NET INCOMEM EUR |
| NET INCOME GROWTH% |
| SHARESM |
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 1.00 | 1.00 | 1.00 | 1.00 | – | – | – | – | – | – | – | 3.00 | – | 5.00 | 5.00 |
| – | -400.00 | -500.00 | -400.00 | -700.00 | – | – | – | – | – | – | – | -133.33 | – | -80.00 | -80.00 |
| -2.00 | -4.00 | -5.00 | -4.00 | -7.00 | -9.00 | -10.00 | -8.00 | -8.00 | -8.00 | -10.00 | -7.00 | -4.00 | -4.00 | -4.00 | -4.00 |
| -3.00 | -1.00 | -6.00 | -8.00 | -12.00 | -11.00 | -15.00 | -15.00 | -14.00 | -13.00 | -13.00 | -13.00 | -9.00 | -6.00 | -6.00 | -9.00 |
| – | -100.00 | -600.00 | -800.00 | -1,200.00 | – | – | – | – | – | – | – | -300.00 | – | -120.00 | -180.00 |
| -3.00 | – | -5.00 | -6.00 | -10.00 | -10.00 | -14.00 | -13.00 | -12.00 | -11.00 | -11.00 | -11.00 | -8.00 | -5.00 | -4.00 | -5.00 |
| 50.00 | – | – | 20.00 | 66.67 | – | 40.00 | -7.14 | -7.69 | -8.33 | – | – | -27.27 | -37.50 | -20.00 | 25.00 |
| 1.65 | 1.82 | 2.76 | 2.78 | 2.82 | 3.35 | 4.55 | 5.17 | 8.86 | 10.29 | 15.10 | 15.22 | 18.03 | 18.32 | 18.32 | 18.32 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Global Bioenergies generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Global Bioenergies retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Global Bioenergies's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Global Bioenergies has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Global Bioenergies's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Global Bioenergies stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Bioenergies Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Global Bioenergies business model & stock analysis
Global Bioenergies SWOT Analysis
Strengths
Global Bioenergies SA has developed innovative technology for converting renewable resources into valuable chemicals.
The company has established strong partnerships with leading companies in the energy, transportation, and chemical industries.
Global Bioenergies SA has a diversified feedstock base, reducing dependency on any single resource.
Weaknesses
As a relatively young company, Global Bioenergies SA may face limited brand recognition and market presence compared to established competitors.
The company's technology is still in the development phase and may require further research and testing before commercialization.
Global Bioenergies SA's financial stability can be a challenge as it requires significant investment to scale up operations and commercialize its technology.
Opportunities
Growing global demand for sustainable alternatives to fossil fuels and petrochemicals presents a significant opportunity for Global Bioenergies SA.
The company can capitalize on increasing government regulations and incentives favoring renewable energy and green technologies.
Expanding into new geographical markets and industries can help Global Bioenergies SA to diversify its customer base.
Threats
Intense competition from well-established players in the biofuels and renewable chemicals industry poses a threat to Global Bioenergies SA's market share.
Volatility in the prices of feedstock resources may impact the company's profitability and operational costs.
Global Bioenergies SA may face regulatory challenges and obstacles in obtaining necessary approvals, permits, and certifications for its technology and products.
Global Bioenergies Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Global Bioenergies historical P/E ratio, EBIT multiple, and P/S ratio
Global Bioenergies annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Global Bioenergies shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Global Bioenergies forecasts and price targets in August 2026
Analyst Price Targets 2026Global Bioenergies shareholder structure
| % | Name |
|---|---|
13.35219% | |
2.65414% | |
0.00000% | |
0.00000% |
Global Bioenergies Executives and Management Board
11 members · avg. age 62 · 18 % women
Dr. Marc Delcourt (53)
Chairman of the Board, Chief Executive Officer · since 2009
175,000.00 EUR
Management
Mr. Samuel Dubruque
Chief Financial Officer
Mr. Martin Stephan
Chief Business Officer
Board of Directors
Mr. Jean-Claude Lumaret (67)
Independent Director
Mr. Pierre Monsan (76)
Independent Director
Mr. Pierre Levi (70)
Independent Director, Representative of Metman Capital
Ms. Marie-Odile Lavenant (59)
Independent Director, Representative of Botheia
Mr. Roland Desvignes
Industrial Director
Mr. Frederic Ollivier
Technical Director
Global Bioenergies Supply Chain
Global Bioenergies Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.25 | 0.16 | 0.25 |
Frequently asked questions about Global Bioenergies
The business model of Global Bioenergies SA is focused on developing and commercializing renewable carbon-based compounds. They utilize proprietary technology to convert renewable resources, such as agricultural and forestry waste, into high-performance products like biofuels and renewable chemicals. Through their innovative approach, Global Bioenergies aims to contribute to the transition towards a more sustainable and environmentally-friendly economy. By utilizing renewable resources, their business model helps reduce reliance on fossil fuels, lower greenhouse gas emissions, and promote the shift towards a circular economy.
Global Bioenergies SA is primarily active in the bioenergy industry. As a leading company in this sector, Global Bioenergies SA focuses on developing innovative solutions for the production of renewable fuels and chemicals. With their advanced biotechnology platform, they aim to reduce dependency on fossil resources and contribute to a more sustainable future. Global Bioenergies SA's expertise lies in the production of bio-based isobutene, a key ingredient in various applications including transportation fuels, plastics, and cosmetics. By harnessing the power of biology, Global Bioenergies SA is revolutionizing the energy and chemical industries with their environmentally friendly solutions.
The main competitors of Global Bioenergies SA in the market include companies like Amyris Inc., REG Life Sciences LLC, Gevo Inc., and LanzaTech Inc. These companies also specialize in the production and development of bio-based products and alternative fuels. However, Global Bioenergies SA stands out in the industry with its unique proprietary technology and strong focus on the commercialization of renewable hydrocarbons.
Global Bioenergies SA is a leading French biotechnology company specializing in renewable resources and the production of alternative fuels. Established in 2008, the company focuses on developing innovative processes to convert renewable resources into hydrocarbons through the use of fermentation. Global Bioenergies SA has achieved significant milestones, such as successfully producing isobutene, a key building block for various applications including biofuels and plastics. By leveraging its expertise in bio-based production, Global Bioenergies SA aims to contribute to reducing greenhouse gas emissions and promoting sustainable alternatives in the energy sector. This company has emerged as a key player in the field of renewable energy solutions.
Global Bioenergies SA has achieved several significant milestones. One of its major achievements includes the successful production of renewable isobutene, a key building block for various sustainable products. The company has also developed a robust portfolio of partnerships and collaborations with renowned companies in the energy and chemical sectors. Furthermore, Global Bioenergies SA has made substantial progress in scaling up its proprietary bioconversion process, showcasing its commitment to commercialization. These accomplishments highlight Global Bioenergies SA's pioneering efforts in the field of renewable energy and its dedication to revolutionizing the bio-based industry.
Global Bioenergies SA is primarily present in several countries and regions worldwide. The company has a strong presence in France, where its headquarters are located. It also operates in Germany, where it has established a subsidiary. Additionally, Global Bioenergies SA has a growing presence in the United States, with ongoing partnerships and collaborations. The company is actively expanding its reach into other European countries, including Spain and the Netherlands, to establish a robust international footprint. With its innovative bio-based processes and technologies, Global Bioenergies SA is continuously broadening its global presence to drive sustainable solutions in the field of renewable energies.
Global Bioenergies SA is a leading company in the field of renewable fuels and chemicals. With a strong commitment to sustainability and innovation, the company aims to transform the energy industry by developing and commercializing advanced biofuels derived from non-food biomass. Global Bioenergies SA values environmental responsibility, aiming to reduce greenhouse gas emissions and promote a cleaner future. With a corporate philosophy centered around technological excellence and collaboration, Global Bioenergies SA strives to revolutionize the energy sector, offering sustainable alternatives with the potential to reshape the way we power our world.
9 analysts currently rate the Global Bioenergies stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Global Bioenergies to generate revenue of 5.41 M EUR and earnings per share of -0.32 EUR.
The Global Bioenergies share (ALGBE.PA) is listed on 3 stock exchanges, including: Frankfurt (1DK.F), Paris (ALGBE.PA).
Global Bioenergies SA is a French company specializing in the development of technologies for renewable energy resources. Its business model is focused on reducing dependence on fossil fuels and instead transitioning to biofuels. The company operates in three main areas: biofuels, industrial chemicals, and food additives. In the biofuels sector, Global Bioenergies has developed an innovative process for converting renewable resources such as sugar or starch into isobutene. Isobutene is an important raw material for the production of biofuels and can be used as a substitute for conventional petroleum. Global Bioenergies has already found various partners who have recognized the potential of isobutene and are interested in its commercial use. For example, the company has entered into a strategic partnership with Audi to work together on the production of biofuels based on isobutene. In the industrial chemicals sector, Global Bioenergies has also developed a process for producing isobutene that can be used for the production of various chemicals. These chemicals are used in various industries, such as solvents or the production of plastics. Here too, the company has already formed partnerships to enable the commercial use of the technology. In the food additives sector, Global Bioenergies has developed a technology that allows for the production of certain flavorings for the food industry based on renewable resources. This technology can be used, for example, to produce vanilla extract. There is a strong interest in the use of renewable resources to meet the growing demand for flavors in the food industry. In addition to these three main areas, Global Bioenergies is also involved in research and development. The company invests in the further development of its technologies and works to expand them to other areas of application. Overall, Global Bioenergies has built a promising business model aimed at using renewable resources for the production of biofuels, industrial chemicals, and food additives. The company has already formed important partnerships and is on track to scale up its technologies commercially. By using renewable resources, Global Bioenergies contributes to reducing dependence on fossil fuels and making a significant contribution to climate protection.
The expected revenue of Global Bioenergies is 5.41 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Global Bioenergies is -5.94 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The P/E ratio cannot be calculated for Global Bioenergies at the moment.
The P/S cannot be calculated for Global Bioenergies currently.
The Eulerpool Quality Score for Global Bioenergies is 3/10.
The ISIN of Global Bioenergies is FR0011052257. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Global Bioenergies is A1JBVH. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Global Bioenergies is ALGBE.PA. The ticker symbol is used to trade Global Bioenergies shares on the stock exchange.
Global Bioenergies is assigned to the 'Commodities' sector.
The dividends of Global Bioenergies are distributed in EUR.
Global Bioenergies stock
Global Bioenergies Peer Group
Global Bioenergies Ticker
Global Bioenergies FIGI
All fundamentals and in-depth analysis of Global Bioenergies
Our stock analysis for Global Bioenergies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Global Bioenergies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.